Drug intelligence / Profile preview

Cetaphil skincare regimen

Development stage
Unknown
Lead developer
Galderma
Administration
Topical
01

Overview

Cetaphil is a well-known brand of skincare products owned by Galderma. In the context of plaque psoriasis, a specific regimen involving Cetaphil Gentle Skin Cleanser, Cetaphil Moisturizing Cream, and Cetaphil Daily Facial Moisturizer SPF 35 has been investigated as an adjunctive therapy to standard prescription treatments. This regimen is intended for patients with mild-to-severe plaque psoriasis to help manage symptoms such as dryness and scaling. The products work by restoring the skin's natural moisture barrier and providing hydration, which can improve the overall tolerability and efficacy of primary pharmacological treatments. A Phase 4 open-label study (NCT05314101) evaluated this regimen's efficacy and tolerability over an 8-week period, demonstrating improvements in skin hydration and desquamation.

Brand names
Cetaphil
Other names
Cetaphil Gentle Skin CleanserCetaphil Moisturizing CreamCetaphil Daily Facial Moisturizer SPF 35

Beyond the preview

Go deeper on Cetaphil skincare regimen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetaphil skincare regimen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call